Sultiame

舒噻美

Report date: 2026/01/30 16:41:17
NME

Base Information

Drug NameSultiame
Drug Alias Namesultiamum苏太明舒噻嗪sultiame硫噻嗪 +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCarbonic anhydrase II inhibitors
TargetsCarbonic anhydrase II
Therapy Area/IndicationsEpilepsySleep Apnea, Obstructive
Global Approved IndicationsEpilepsy
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2001/12/01
Country/TerritoryBelgiumJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesDesitin Arzneimittel Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesKyowa Pharmaceutical Industry Co LtdApnimed IncDesitin Arzneimittel Gmbh +[4] 
Inactive CompaniesN/A
Active IndicationsEpilepsySleep Apnea, Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN03AX03
Related LinksWikipediaKEGG